CEBP Frontiers in Cancer Prevention Research - 2008 Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nomura, A. M. Y.
Right arrow Articles by Combs, G. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nomura, A. M. Y.
Right arrow Articles by Combs, G. F., Jr.
Cancer Epidemiology Biomarkers & Prevention Vol. 9, 883-887, September 2000
© 2000 American Association for Cancer Research

Serum Selenium and Subsequent Risk of Prostate Cancer1

Abraham M. Y. Nomura2, James Lee, Grant N. Stemmermann and Gerald F. Combs, Jr.

Japan-Hawaii Cancer Study, Kuakini Medical Center, Honolulu, Hawaii 96817 [A. M. Y. N., J. L.]; Department of Pathology, University of Cincinnati Medical Center, Cincinnati, Ohio 45267 [G. N. S.]; Division of Nutritional Sciences, Cornell University, Ithaca, New York 14853 [G. F. C.]

It is suspected that selenium is protective against prostate cancer. To test this hypothesis, we conducted a nested case-control study in a cohort of 9345 Japanese-American men examined between 1971 and 1977. At the time of examination, a blood specimen was obtained, and the serum was frozen. After a surveillance period of more than 20 years, 249 tissue-confirmed incident cases of prostate cancer were identified. Their stored sera and those of 249 matched controls were measured for selenium levels. Odds ratios for prostate cancer, based on quartiles of serum selenium levels, were determined using the General Estimating Equations approach. The multivariate odds ratio for the highest quartile was 0.5 (95% confidence interval, 0.3–0.9) with a two-sided P for trend of 0.02. The inverse association was more notable for cases with advanced disease and for cases diagnosed 5–15 years after phlebotomy. However, the association was mainly present in current or past cigarette smokers rather than nonsmokers, which leads to caution in the interpretation of the results.




This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
D. J. Waters, S. Shen, H. Xu, S. S. Kengeri, D. M. Cooley, E. C. Chiang, Y. Chen, D. Schlittler, C. Oteham, G. F. Combs Jr., et al.
Noninvasive Prediction of Prostatic DNA Damage by Oxidative Stress Challenge of Peripheral Blood Lymphocytes
Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1906 - 1910.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
J. Y. Chun, Y. Hu, E. Pinder, J. Wu, F. Li, and A. C. Gao
Selenium inhibition of survivin expression by preventing Sp1 binding to its promoter
Mol. Cancer Ther., September 1, 2007; 6(9): 2572 - 2580.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
U. Peters, C. B Foster, N. Chatterjee, A. Schatzkin, D. Reding, G. L Andriole, E D. Crawford, S. Sturup, S. J Chanock, and R. B Hayes
Serum selenium and risk of prostate cancer--a nested case-control study
Am. J. Clinical Nutrition, January 1, 2007; 85(1): 209 - 217.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. R. Marshall, W. Sakr, D. Wood, D. Berry, C. Tangen, F. Parker, I. Thompson, S. M. Lippman, R. Lieberman, D. Alberts, et al.
Design and Progress of a Trial of Selenium to Prevent Prostate Cancer among Men with High-Grade Prostatic Intraepithelial Neoplasia.
Cancer Epidemiol. Biomarkers Prev., August 1, 2006; 15(8): 1479 - 1484.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
J. Y. Chun, N. Nadiminty, S. O. Lee, S. A. Onate, W. Lou, and A. C. Gao
Mechanisms of selenium down-regulation of androgen receptor signaling in prostate cancer.
Mol. Cancer Ther., April 1, 2006; 5(4): 913 - 918.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. L. Sabichi, J. J. Lee, R. J. Taylor, I. M. Thompson, B. J. Miles, C. M. Tangen, L. M. Minasian, L. L. Pisters, J. R. Caton, J. W. Basler, et al.
Selenium accumulation in prostate tissue during a randomized, controlled short-term trial of l-selenomethionine: a Southwest Oncology Group Study.
Clin. Cancer Res., April 1, 2006; 12(7 Pt 1): 2178 - 2184.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J. M. Chan, P. H. Gann, and E. L. Giovannucci
Role of Diet in Prostate Cancer Development and Progression
J. Clin. Oncol., November 10, 2005; 23(32): 8152 - 8160.
[Abstract] [Full Text] [PDF]


Home page
ANN BOT (LOND)Home page
J. W. FINLEY
Proposed Criteria for Assessing the Efficacy of Cancer Reduction by Plant Foods Enriched in Carotenoids, Glucosinolates, Polyphenols and Selenocompounds
Ann. Bot., June 1, 2005; 95(7): 1075 - 1096.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
P. R. Taylor and P. Greenwald
Nutritional Interventions in Cancer Prevention
J. Clin. Oncol., January 10, 2005; 23(2): 333 - 345.
[Abstract] [Full Text] [PDF]


Home page
Integr Cancer TherHome page
M. F. McCarty
Targeting Multiple Signaling Pathways as a Strategy for Managing Prostate Cancer: Multifocal Signal Modulation Therapy
Integr Cancer Ther, December 1, 2004; 3(4): 349 - 380.
[Abstract] [PDF]


Home page
JNCI J Natl Cancer InstHome page
P. R. Taylor, H. L. Parnes, and S. M. Lippman
Science Peels the Onion of Selenium Effects on Prostate Carcinogenesis
J Natl Cancer Inst, May 5, 2004; 96(9): 645 - 647.
[Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
H. Li, M. J. Stampfer, E. L. Giovannucci, J. S. Morris, W. C. Willett, J. M. Gaziano, and J. Ma
A Prospective Study of Plasma Selenium Levels and Prostate Cancer Risk
J Natl Cancer Inst, May 5, 2004; 96(9): 696 - 703.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
H. Zhao, M. L. Whitfield, T. Xu, D. Botstein, and J. D. Brooks
Diverse Effects of Methylseleninic Acid on the Transcriptional Program of Human Prostate Cancer Cells
Mol. Biol. Cell, February 1, 2004; 15(2): 506 - 519.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
P. A. van den Brandt, M. P. A. Zeegers, P. Bode, and R. A. Goldbohm
Toenail Selenium Levels and the Subsequent Risk of Prostate Cancer: A Prospective Cohort Study
Cancer Epidemiol. Biomarkers Prev., September 1, 2003; 12(9): 866 - 871.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
S. Wilkinson and G. W. Chodak
Critical Review of Complementary Therapies for Prostate Cancer
J. Clin. Oncol., June 1, 2003; 21(11): 2199 - 2210.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. D. Brooks, M. F. Goldberg, L. A. Nelson, D. Wu, and W. G. Nelson
Identification of Potential Prostate Cancer Preventive Agents through Induction of Quinone Reductase in Vitro
Cancer Epidemiol. Biomarkers Prev., September 1, 2002; 11(9): 868 - 875.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. J. Duffield-Lillico, M. E. Reid, B. W. Turnbull, G. F. Combs Jr., E. H. Slate, L. A. Fischbach, J. R. Marshall, and L. C. Clark
Baseline Characteristics and the Effect of Selenium Supplementation on Cancer Incidence in a Randomized Clinical Trial: A Summary Report of the Nutritional Prevention of Cancer Trial
Cancer Epidemiol. Biomarkers Prev., July 1, 2002; 11(7): 630 - 639.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
G. E. Goodman, S. Schaffer, D. D. Bankson, M. P. Hughes, and G. S. Omenn
Predictors of Serum Selenium in Cigarette Smokers and the Lack of Association with Lung and Prostate Cancer Risk
Cancer Epidemiol. Biomarkers Prev., October 1, 2001; 10(10): 1069 - 1076.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
E. Giovannucci
{{gamma}}-Tocopherol: a New Player in Prostate Cancer Prevention?
J Natl Cancer Inst, December 20, 2000; 92(24): 1966 - 1967.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.